Evidence map›Paper›PMID 42729033›Full record

ArticleOpen research Europe2025

Behavioural analysis of referral and uptake of care pathways for rare tumour risk syndromes: A cross-cultural mixed-methods study protocol within the PREVENTABLE project.

Ana Machado, Maiara Moreto, Isabel Fernandes, Ana Maria Rodrigues, Bárbara Peleteiro, Joan Brunet, Judith Balmaña, Claude Houdayer, Jean-Christophe Thery, Janneke H M Schuurs-Hoeijmakers and 7 more

Abstract read
In one paragraph

Article in Open research Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ana Machado *Comprehensive Health Research Centre (CHRC), NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal.ORCID https://orcid.org/0000-0002-4427-2695
Maiara Moreto *Comprehensive Health Research Centre (CHRC), NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal.ORCID https://orcid.org/0009-0004-2223-733X
Isabel FernandesComprehensive Health Research Centre (CHRC), NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal.
Ana Maria RodriguesComprehensive Health Research Centre (CHRC), NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal.
Bárbara PeleteiroHospital Epidemiology Center, Unidade Local de Saúde São João, Porto, Portugal.
Joan BrunetCatalan Institute of Oncology, Barcelona-Girona, Spain.ORCID https://orcid.org/0000-0003-1945-3512
Judith BalmañaERN GENTURIS - European Reference Network on Genetic Tumour Risk Syndromes, Nijmegen, The Netherlands.
Claude HoudayerERN GENTURIS - European Reference Network on Genetic Tumour Risk Syndromes, Nijmegen, The Netherlands.
Jean-Christophe TheryDepartment of Medical Oncology, Center Henri Becquerel, University of Medicine of Rouen, Rouen, France.
Janneke H M Schuurs-HoeijmakersERN GENTURIS - European Reference Network on Genetic Tumour Risk Syndromes, Nijmegen, The Netherlands.
Stefan AretzERN GENTURIS - European Reference Network on Genetic Tumour Risk Syndromes, Nijmegen, The Netherlands.
Cathrine BjorvatnDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0003-1454-4925
Liliana SousaERN GENTURIS - European Reference Network on Genetic Tumour Risk Syndromes, Nijmegen, The Netherlands.
Sara PereiraUniversidade do Porto Instituto de Investigacao e Inovacao em Saude, Porto, Portugal.
Carla OliveiraFaculty of Medicine, University of Porto, Porto, Portugal.
PREVENTABLE Clinical Research Team
Marta M MarquesNew University of Lisbon Comprehensive Health Research Centre National School of Public Health, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Individuals with rare tumour risk syndromes (RTRS) navigate complex care pathways, including early diagnosis, monitoring, and tailored treatments, all requiring shared decision-making with their clinical team. Nevertheless, behavioural factors influencing this decision-making process and the best communication practices are unknown. Objective: This study aims to identify the behavioural factors (i.e., barriers and facilitators) influencing i. the recommendation of RTRS-care pathways by members of clinical teams, ii. the uptake of the care pathways by patients with RTRS, and iii. The factors experienced by patients' social networks. This study is part of PREVENTABLE, an EU-Horizon funded project, aiming to assess the clinical, social and economic impact of RTRS-care pathways. Methods: A cross-cultural mixed-methods study with a sequential explanatory design will be conducted, consisting of i. a web-based survey study (quantitative phase), and ii. a qualitative study conducted through focus groups (qualitative phase). First, two international web-based surveys, following the COM-B model of behavioural change, will be developed aiming to investigate the barriers and facilitators to i) the recommendations of RTRS-care pathways by 100 members of clinical teams managing these syndromes, and ii) the uptake of the recommended care pathways by 290 patients with RTRS. The results will inform the focus groups phase aiming to provide an in-depth exploration of the main factors affecting the recommendation and adoption of RTRS-care pathways. The study will involve six countries, i.e., France, Germany, Netherlands, Norway, Spain, and Portugal. Both qualitative and quantitative data will first be analyzed separately, and then merged through data triangulation for final interpretation of the results. Conclusion: This will be the first study exploring the behavioural factors influencing the recommendation and uptake of RTRS-care pathways. This study will guide the development of guidelines for the communication and recommendation of optimized care pathways for RTRS, which might enhance the referral and uptake of RTRS preventive strategies and inform the best care for RTRS.

Indexed as

barriers; facilitators; communication; behaviour change; decision-making; hereditary cancer; rare diseases

Identifiers

PMID42729033
PMCPMC13560810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.